Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
Number of Votes Cast ForPHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") announced today the results of the Annual Meeting of Shareholders (the "Meeting"), held on June 25, 2024.
2024年6月26日，hql基金（"abrdn Life Sciences Investors"）宣布股东年会（"会议"）的结果，会议于2024年6月25日举行。
As of the record date, April 1, 2024, HQL had outstanding 27,350,517 shares of common stock. 87.84% of outstanding common stock were voted representing a quorum.
截至记录日期2024年4月1日，hql基金拥有27,350,517股普通股，占全部普通股的87.84%，代表法定人数的投票。
Shareholders approved the election of two Class B Trustees to the Board to serve until 2027 Annual Meeting by the following votes:
股东们通过了以下选票，批准了两名B类董事会受托人当选为董事会成员，任期至2027年年度股东大会：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
|
| Stephen Bird | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| Jeffrey Bailey | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
投票支持人数 |
投票支持百分比 |
投票反对/弃权人数 |
投票反对/弃权百分比 |
|
| 史蒂芬·伯德 | 20,269,963 |
84.4% |
3,753,701 |
15.6% |
| 杰弗里·贝利 | 19,670,734 |
81.9% |
4,352,930 |
18.1% |
Shareholders opposed a shareholder proposal regarding annual terms of trustees by the following votes:
股东们否决了有关董事年度任期的股东提案，以下为反对票：
Number of Votes Cast For |
Percentage of Votes Cast For |
Number of Votes Cast Against/Withheld |
Percentage of Votes Cast Against / Withheld |
Number of Votes |
Percentage |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
投票支持人数 |
投票支持百分比 |
投票反对/弃权人数 |
投票反对/弃权百分比 |
得票数 |
百分比 |
6,891,241 |
41.6% |
9,133,348 |
55.1% |
533,327 |
3.3% |
In the United States, abrdn is the marketing name for the following affiliated, registered investment advisers: abrdn Inc., abrdn Investments Limited, abrdn Asia Limited, and abrdn ETFs Advisors LLC.
在美国，abrdn是以下注册投资顾问的市场营销名称：abrdn Inc.，abrdn Investments Limited，abrdn Asia Limited和abrdn ETFs Advisors LLC。
Closed-end funds are traded on the secondary market through one of the stock exchanges. A Fund's investment return and principal value will fluctuate so that an investor's shares may be worth more or less than the original cost. Shares of closed-end funds may trade above (a premium) or below (a discount) the net asset value (NAV) of the fund's portfolio. There is no assurance that a Fund will achieve its investment objective. Past performance does not guarantee future results.
封闭式基金通过一家股票交易所在二级市场交易。基金的投资回报和本金价值将波动，因此投资者的股份可能比原始成本价值高或低。封闭式基金的股份可能高于（溢价）或低于（折价）基金组合的净资产价值（NAV）。基金将达到其投资目标不能保证。过去的业绩不代表未来的结果。
# # #
# # #
For More Information Contact:
abrdn U.S. Closed-End Funds
Investor Relations
800-522-5465
Investor.Relations@abrdn.com
欲知详情，请联系：
abrdn美国封闭式基金
投资者关系
800-522-5465
Investor.Relations@abrdn.com
SOURCE: abrdn U.S. Closed-End Funds
来源：abrdn美国封闭式基金
